Lombard Odier Asset Management (Europe) LTD Astrazeneca PLC Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $2,197 - $2,504	-36 Reduced 0.14%	26,272 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $5,013 - $5,611	81 Added 0.31%	26,308 $1.77 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $4,215 - $4,660	-65 Reduced 0.25%	26,227 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $74,593 - $80,889	-1,067 Reduced 3.9%	26,292 $1.88 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $157,180 - $178,212	-2,489 Reduced 8.34%	27,359 $1.9 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $66,081 - $85,866	-1,219 Reduced 3.92%	29,848 $2.02 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $183,608 - $470,102	-3,463 Reduced 10.03%	31,067 $1.7 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $2.05 Million - $2.46 Million	34,530 New	34,530 $2.28 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.11 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.74 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.43 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.41 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.25 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account